Prendergast GC - Search Results

1

CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion.

Jiao X, Velasco-Velázquez MA, Wang M, Li Z, Rui H, Peck AR, Korkola JE, Chen X, Xu S, DuHadaway JB, Guerrero-Rodriguez S, Addya S, Sicoli D, Mu Z, Zhang G, Stucky A, Zhang X, Cristofanilli M, Fatatis A, Gray JW, Zhong JF, Prendergast GC, Pestell RG. Jiao X, et al. Among authors: prendergast gc. Cancer Res. 2018 Apr 1;78(7):1657-1671. doi: 10.1158/0008-5472.CAN-17-0915. Epub 2018 Jan 22. Cancer Res. 2018. PMID: 29358169 Free PMC article.

2

Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing.

Wechsler-Reya R, Sakamuro D, Zhang J, Duhadaway J, Prendergast GC. Wechsler-Reya R, et al. Among authors: prendergast gc. J Biol Chem. 1997 Dec 12;272(50):31453-8. doi: 10.1074/jbc.272.50.31453. J Biol Chem. 1997. PMID: 9395479 Free article.

3

Elevation of alpha2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitors.

Du W, Lebowitz PF, Prendergast GC. Du W, et al. Among authors: prendergast gc. Cancer Res. 1999 May 1;59(9):2059-63. Cancer Res. 1999. PMID: 10232587

4

Bau, a splice form of Neurabin-I that interacts with the tumor suppressor Bin1, inhibits malignant cell transformation.

Duhadaway J, Rowe F, Elliott K, Mao NC, Prendergast GC. Duhadaway J, et al. Among authors: prendergast gc. Cell Adhes Commun. 1999;7(2):99-110. doi: 10.3109/15419069909034394. Cell Adhes Commun. 1999. PMID: 10427963

5

Activation of the PI3'K-AKT pathway masks the proapoptotic effects of farnesyltransferase inhibitors.

Du W, Liu A, Prendergast GC. Du W, et al. Among authors: prendergast gc. Cancer Res. 1999 Sep 1;59(17):4208-12. Cancer Res. 1999. PMID: 10485456

6

Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitors.

Du W, Prendergast GC. Du W, et al. Among authors: prendergast gc. Cancer Res. 1999 Nov 1;59(21):5492-6. Cancer Res. 1999. PMID: 10554025

7

Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity.

Ge K, Duhadaway J, Sakamuro D, Wechsler-Reya R, Reynolds C, Prendergast GC. Ge K, et al. Among authors: prendergast gc. Int J Cancer. 2000 Feb 1;85(3):376-83. Int J Cancer. 2000. PMID: 10652430 Free article.

8

Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma.

Ge K, Minhas F, Duhadaway J, Mao NC, Wilson D, Buccafusca R, Sakamuro D, Nelson P, Malkowicz SB, Tomaszewski J, Prendergast GC. Ge K, et al. Among authors: prendergast gc. Int J Cancer. 2000 Apr 15;86(2):155-61. doi: 10.1002/(sici)1097-0215(20000415)86:2<155::aid-ijc2>3.0.co;2-m. Int J Cancer. 2000. PMID: 10738240 Free article.

9

Bin1 mediates apoptosis by c-Myc in transformed primary cells.

DuHadaway JB, Sakamuro D, Ewert DL, Prendergast GC. DuHadaway JB, et al. Among authors: prendergast gc. Cancer Res. 2001 Apr 1;61(7):3151-6. Cancer Res. 2001. PMID: 11306501

10

Immunohistochemical analysis of Bin1/Amphiphysin II in human tissues: diverse sites of nuclear expression and losses in prostate cancer.

DuHadaway JB, Lynch FJ, Brisbay S, Bueso-Ramos C, Troncoso P, McDonnell T, Prendergast GC. DuHadaway JB, et al. Among authors: prendergast gc. J Cell Biochem. 2003 Feb 15;88(3):635-42. doi: 10.1002/jcb.10380. J Cell Biochem. 2003. PMID: 12532338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page